Company Search:
Advanced Search
Sponsored Links
Biosynex SA Company Snapshot
Biosynex SA operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biosynex SA with three other pharmaceutical manufacturers in Europe: Millet Innovation Sa (2015 sales of 21.81 million Euro [US$23.94 million] of which 93% was Pharmacies & Pharmaceutical Wholesale De), Biosearch SA of Spain (19.21 million Euro [US$21.09 million] of which 94% was Product Sales), and Mithra Pharmaceuticals SA which is based in Belgium (20.44 million Euro [US$22.43 million] ).

Sales Analysis. Sales increased substantially in 2015: During the year ended December of 2015, sales at Biosynex SA were 20.13 million Euro (US$22.10 million). This is an increase of 394.2% versus 2014, when the company's sales were 4.07 million Euro. This was the fifth consecutive year of sales increases at Biosynex SA (and since 2010, sales have increased a total of 1,899%). Sales of Services saw an increase that was more than double the company's growth rate: sales were up 1,415.1% in 2015, from 76,876.00 Euro to 1.16 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biosynex SA
  Stock Performance Chart for Biosynex SA
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2016): 2.63
(Figures in Euro)
1 Week -7.7%   13 Weeks -11.4%  
4 Weeks -13.8%   52 Weeks -18.4%  
Biosynex SA Key Data:
  Ticker: ALBIO Country: France
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 20,131,000
(Year Ending Jan 2016).
Employees: 49
  Currency: Euro Market Cap: 16,243,119
  Fiscal Yr Ends: December Shares Outstanding: 6,176,091
  Share Type: Actions Ordinaires Closely Held Shares: 468,081
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.